Author:
Neumann-Klimasińska Natalia,Merritt T. Allen,Beck Jennifer,Miechowicz Izabela,Szymankiewicz-Bręborowicz Marta,Szczapa Tomasz
Abstract
AbstractDue to its unique properties, helium–oxygen (heliox) mixtures may provide benefits during non-invasive ventilation, however, knowledge regarding the effects of such therapy in premature infants is limited. This is the first report of heliox non-invasive neurally adjusted ventilatory assist (NIV-NAVA) ventilation applied in neonates born ≤ 32 weeks gestational age. After baseline NIV-NAVA ventilation with a standard mixture of air and oxygen, heliox was introduced for 3 h, followed by 3 h of air-oxygen. Heart rate, peripheral capillary oxygen saturation, cerebral oxygenation, electrical activity of the diaphragm (Edi) and selected ventilatory parameters (e.g., respiratory rate, peak inspiratory pressure) were continuously monitored. We found that application of heliox NIV-NAVA in preterm infants was feasible and associated with a prompt and significant decrease of Edi suggesting reduced respiratory effort, while all other parameters were stable throughout the study, and had similar values during heliox and air-oxygen ventilation. This therapy may potentially enhance the efficacy of non-invasive respiratory support in preterm neonates and reduce the number of infants progressing to ventilatory failure.
Funder
European Society for Paediatric Research
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Hess, D. R. et al. The history and physics of heliox. Respir. Care 51(6), 608–612 (2006).
2. Kass, J. E. Heliox redux. Chest 123(3), 673–676 (2003).
3. Myers, T. R. Use of heliox in children. Respir. Care 51(6), 619–631 (2006).
4. Venkataraman, S. T. Heliox during mechanical ventilation. Respir. Care 51(6), 632–639 (2006).
5. Szczapa, T. & Gadzinowski, J. Use of heliox in the management of neonates with meconium aspiration syndrome. Neonatology 100(3), 265–270 (2011).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献